Post-menopause is the period of life where a deep decline occurs in circulating estrogen levels, inducing the appearance of psycho and somatic symptoms. The classification to understand the chronology of reproductive aging in women (known as STRAW) determines the clinical and endocrine changes contemplating menstrual cycles, symptoms, measurements of FSH, LH, inhibin B, anti-Mullerian hormone , and follicular account. The diagnosis of menopause is established by the absence of menstruation for 12 months or more. The most frequent clinical manifestations of the climacteric syndrome transition to menopause are menstrual disorders, vasomotor symptoms (flushes and/or sweats) and genitourinary manifestations. The assessment of women in the peri- or postmenopause aims to develop: cervicovaginal cytology , lipid profile , serum glucose, basal Mammography at least a year before, pelvic ultrasound, urinalysis, serum TSH, Densitometry in patients older than 60 years if there is no recourse can be applied and FRAX. Drug therapy for the treatment of disorders of the transition to menopause or menopause is divided into: hormone therapy (HT) based estrogens and progestin hormone not being the most recommended the serotonin reuptake inhibitors and norepinephrine, clonidine, gabapentin or veralipride.
Select Content Type
Clinical Guidelines
Interests
Obstetrics & Gynecology
Endocrinology
Internal/Family Medicine
Speciality
Obstetrics & Gynecology
Endocrinology
Internal/Family Medicine
Book Detail
volume
53
ISSN
2448-5667
Publication Date
Actions
Download in App
Event Data
{"article_title":"[Clinical practice guideline. Diagnosis and treatment of postmenopausal and perinemopausia].","author":"Alvarado-Garc\u00eda A, Hern\u00e1ndez-Quijano T, Hern\u00e1ndez-Valencia M, Negr\u00edn-P\u00e9rez MC, R\u00edos-Castillo B, Valencia-P\u00e9rez GU, Vital-Reyes VS, Basavilvazo-Rodr\u00edguez MA, Torres-Arreola LP, Ortiz-Luna GF, S\u00e1nchez-Aguirre F, Monta\u00f1o-Uscanga A","journal_title":"Revista medica del Instituto Mexicano del Seguro Social","issn":"2448-5667","isbn":"","publication_date":"2021 May","volume":"53","issue":"2","first_page":"214","page_count":"","accession_number":"25760751","doi":"","publisher":"Coordinacio\u0301n de Educacio\u0301n en Salud, Divisio\u0301n de Innovacio\u0301n Educativa","doctype":"Journal Article","subjects":"Female Urogenital Diseases diagnosis; Female Urogenital Diseases etiology; Female Urogenital Diseases therapy; Hot Flashes diagnosis; Hot Flashes etiology; Hot Flashes therapy; Menopause physiology; Menstruation Disturbances diagnosis; Menstruation Disturbances etiology; Menstruation Disturbances therapy; Osteoporosis, Postmenopausal diagnosis; Osteoporosis, Postmenopausal therapy; Female; Humans; Postmenopause physiology; Syndrome","interest_area":["Obstetrics & Gynecology"," Endocrinology"," Internal Medicine"],"abstract":"Post-menopause is the period of life where a deep decline occurs in circulating estrogen levels, inducing the appearance of psycho and somatic symptoms. The classification to understand the chronology of reproductive aging in women (known as STRAW) determines the clinical and endocrine changes contemplating menstrual cycles, symptoms, measurements of FSH, LH, inhibin B, anti-Mullerian hormone , and follicular account. The diagnosis of menopause is established by the absence of menstruation for 12 months or more. The most frequent clinical manifestations of the climacteric syndrome transition to menopause are menstrual disorders, vasomotor symptoms (flushes and\/or sweats) and genitourinary manifestations. The assessment of women in the peri- or postmenopause aims to develop: cervicovaginal cytology , lipid profile , serum glucose, basal Mammography at least a year before, pelvic ultrasound, urinalysis, serum TSH, Densitometry in patients older than 60 years if there is no recourse can be applied and FRAX. Drug therapy for the treatment of disorders of the transition to menopause or menopause is divided into: hormone therapy (HT) based estrogens and progestin hormone not being the most recommended the serotonin reuptake inhibitors and norepinephrine, clonidine, gabapentin or veralipride.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=25760751&authtype=shib&custid=ns346513&group=main&profile=eds","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Alvarado-Garc\u00eda A, Hern\u00e1ndez-Quijano T, Hern\u00e1ndez-Valencia M, Negr\u00edn-P\u00e9rez MC, R\u00edos-Castillo B, Valencia-P\u00e9rez GU, Vital-Reyes VS, Basavilvazo-Rodr\u00edguez MA, Torres-Arreola LP, Ortiz-Luna GF, S\u00e1nchez-Aguirre F, Monta\u00f1o-Uscanga A","Journal_Info":"Publisher: Coordinacio\u0301n de Educacio\u0301n en Salud, Divisio\u0301n de Innovacio\u0301n Educativa Country of Publication: Mexico NLM ID: 101243727 Publication Model: Print Cited Medium: Internet ISSN: 2448-5667 (Electronic) Linking ISSN: 04435117 NLM ISO Abbreviation: Rev Med Inst Mex Seguro Soc Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2015-03-01","Source":"Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2015 Mar-Apr; Vol. 53 (2), pp. 214-25.","Languages":"Spanish; Castilian","Electronic_ISSN":"2448-5667","MeSH_Terms":"Female Urogenital Diseases*\/diagnosis , Female Urogenital Diseases*\/etiology , Female Urogenital Diseases*\/therapy , Hot Flashes*\/diagnosis , Hot Flashes*\/etiology , Hot Flashes*\/therapy , Menstruation Disturbances*\/diagnosis , Menstruation Disturbances*\/etiology , Menstruation Disturbances*\/therapy , Osteoporosis, Postmenopausal*\/diagnosis , Osteoporosis, Postmenopausal*\/therapy, Menopause\/*physiology, Female ; Humans ; Postmenopause\/physiology ; Syndrome","Subjects":"Female, Humans, Postmenopause physiology, Syndrome, Female Urogenital Diseases diagnosis, Female Urogenital Diseases etiology, Female Urogenital Diseases therapy, Hot Flashes diagnosis, Hot Flashes etiology, Hot Flashes therapy, Menopause physiology, Menstruation Disturbances diagnosis, Menstruation Disturbances etiology, Menstruation Disturbances therapy, Osteoporosis, Postmenopausal diagnosis, Osteoporosis, Postmenopausal therapy","Title_Abbreviations":"Revista medica del Instituto Mexicano del Seguro Social","Volume":"53"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"25760751","RelevancyScore":"794","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"794.364929199219"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=25760751&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=25760751&authtype=shib&custid=ns346513&group=main&profile=eds"}
ISSN
2448-5667
IS_Ebsco
true
Upload Link
https://search.ebscohost.com/login.aspx?direct=true&db=mdl&AN=25760751&authtype=shib&custid=ns346513&group=main&profile=eds
Additional Info
["Alvarado-Garc\u00eda A, Hern\u00e1ndez-Quijano T, Hern\u00e1ndez-Valencia M, Negr\u00edn-P\u00e9rez MC, R\u00edos-Castillo B, Valencia-P\u00e9rez GU, Vital-Reyes VS, Basavilvazo-Rodr\u00edguez MA, Torres-Arreola LP, Ortiz-Luna GF, S\u00e1nchez-Aguirre F, Monta\u00f1o-Uscanga A","Publisher: Coordinacio\u0301n de Educacio\u0301n en Salud, Divisio\u0301n de Innovacio\u0301n Educativa Country of Publication: Mexico NLM ID: 101243727 Publication Model: Print Cited Medium: Internet ISSN: 2448-5667 (Electronic) Linking ISSN: 04435117 NLM ISO Abbreviation: Rev Med Inst Mex Seguro Soc Subsets: MEDLINE","Journal Article; Practice Guideline","2015-03-01","Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2015 Mar-Apr; Vol. 53 (2), pp. 214-25.","Spanish; Castilian","2448-5667","Female Urogenital Diseases*\/diagnosis , Female Urogenital Diseases*\/etiology , Female Urogenital Diseases*\/therapy , Hot Flashes*\/diagnosis , Hot Flashes*\/etiology , Hot Flashes*\/therapy , Menstruation Disturbances*\/diagnosis , Menstruation Disturbances*\/etiology , Menstruation Disturbances*\/therapy , Osteoporosis, Postmenopausal*\/diagnosis , Osteoporosis, Postmenopausal*\/therapy, Menopause\/*physiology, Female ; Humans ; Postmenopause\/physiology ; Syndrome","Female, Humans, Postmenopause physiology, Syndrome, Female Urogenital Diseases diagnosis, Female Urogenital Diseases etiology, Female Urogenital Diseases therapy, Hot Flashes diagnosis, Hot Flashes etiology, Hot Flashes therapy, Menopause physiology, Menstruation Disturbances diagnosis, Menstruation Disturbances etiology, Menstruation Disturbances therapy, Osteoporosis, Postmenopausal diagnosis, Osteoporosis, Postmenopausal therapy","Revista medica del Instituto Mexicano del Seguro Social","53"]
Description